✦ LIBER ✦

Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients

✍ Scribed by L. Wang; F. Liu; Y.-D. Liu; X.-Y. Li; J.-B. Wang; Z.-H. Zhang; Y.-Z. Wang

Book ID: 108886329
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 87 KB
Volume: 17
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2009.01178.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Poor durability of lamivudine effectiven

Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients

✍ Feng Liu; Lei Wang; Xiao Ying Li; You De Liu; Jing Bo Wang; Zhao Hua Zhang; Yao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 365 KB

A prospective clinical study in hepatiti

A prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients with stringent cessation criteria for adefovir

✍ Minghao Ha; Guotong Zhang; Shu Diao; Mingfang Lin; Liping Sun; Huiyuan She; Chen 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 179 KB

Durability of peginterferon alfa-2b trea

Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen–positive chronic hepatitis B

✍ Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Kenneth Kar-Lung Yan; Angel Mei-Ling 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 2 views

Cost-effectiveness of peginterferon alfa

Cost-effectiveness of peginterferon alfa-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan

✍ Sean D Sullivan; David L Veenstra; Pei-Jer Chen; Ting-Tsung Chang; Wan-Long Chua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Early hepatitis B virus DNA reduction in

Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovir

✍ Nancy Leung; Cheng-Yuan Peng; Hie-Won Hann; Jose Sollano; Judy Lao-Tan; Chao-Wei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views

This study was undertaken to compare the early antiviral activity and viral kinetic profiles of entecavir (ETV) versus adefovir (ADV) in hepatitis B e antigen positive nucleoside-naïve adults with chronic hepatitis B (CHB). Sixty-nine nucleoside-naïve CHB patients with baseline HBV DNA of 10(8) copi

Interferon α-2b with and without ribavir

Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen–positive chronic hepatitis B: A randomized study

✍ Chun-Jen Liu; Ming-Yang Lai; You-Chen Chao; Li-Ying Liao; Sien-Sing Yang; Tun-Je 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

To study whether interferon (IFN) ␣ and ribavirin combination therapy has a beneficial effect for hepatitis B e antigen (HBeAg)-positive chronic hepatitis B, we enrolled 119 such patients in a randomized study. Fifty-nine patients received 5 million units of IFN-␣2b daily for 4 weeks followed by 5 m